Literature DB >> 11104792

Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice.

J Cole1, D Ertoy, H Lin, R L Sutliff, E Ezan, T T Guyene, M Capecchi, P Corvol, K E Bernstein.   

Abstract

While nephrologists often observe reduced hematocrit associated with inhibitors of angiotensin-converting enzyme (ACE), the basis for this effect is not well understood. We now report that two strains of ACE knockout mice have a normocytic anemia associated with elevated plasma erythropoietin levels. (51)Cr labeling of red cells showed that the knockout mice have a normal total blood volume but a reduced red cell mass. ACE knockout mice, which lack tissue ACE, are anemic despite having normal renal function. These mice have increased plasma levels of the peptide acetyl-SDKP, a possible stem cell suppressor. However, they also show low plasma levels of angiotensin II. Infusion of angiotensin II for 2 weeks increased hematocrit to near normal levels. These data suggest that angiotensin II facilitates erythropoiesis, a conclusion with implications for the management of chronically ill patients on inhibitors of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11104792      PMCID: PMC381466          DOI: 10.1172/JCI10557

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  The effect of angiotensin II receptor antagonist on the exogenous erythropoietin requirement of haemodialysis patients.

Authors:  C G Chew; M D Weise; A P Disney
Journal:  Nephrol Dial Transplant       Date:  1999-08       Impact factor: 5.992

2.  Effects of enalapril on erythrocytosis after renal transplantation.

Authors:  R S Gaston; B A Julian; A G Diethelm; J J Curtis
Journal:  Ann Intern Med       Date:  1991-12-15       Impact factor: 25.391

3.  Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

Authors:  M Lenfant; J Wdzieczak-Bakala; E Guittet; J C Prome; D Sotty; E Frindel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

4.  The beneficial effect of enalapril on erythrocytosis after renal transplantation.

Authors:  P J Conlon; J Farrell; J Donohoe; J J Walshe
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

5.  Effect of enalapril on haemoglobin and serum erythropoietin in patients with chronic nephropathy.

Authors:  A L Kamper; O J Nielsen
Journal:  Scand J Clin Lab Invest       Date:  1990-10       Impact factor: 1.713

6.  Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassay.

Authors:  P Pradelles; Y Frobert; C Créminon; E Liozon; A Massé; E Frindel
Journal:  Biochem Biophys Res Commun       Date:  1990-08-16       Impact factor: 3.575

7.  Erythropoietin production in exhypoxic polycythemic mice.

Authors:  I Seferynska; J Brookins; J C Rice; J W Fisher
Journal:  Am J Physiol       Date:  1989-04

8.  Enalapril (MK-421) and the white cell count and haematocrit.

Authors:  G T Griffing; J C Melby
Journal:  Lancet       Date:  1982-06-12       Impact factor: 79.321

9.  Elevated level of erythropoietin in congestive heart failure relationship to renal perfusion and plasma renin.

Authors:  J D Jensen; H Eiskjaer; J P Bagger; E B Pedersen
Journal:  J Intern Med       Date:  1993-02       Impact factor: 8.989

10.  The mechanism of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of haematopoietic stem cell proliferation.

Authors:  S Robinson; M Lenfant; J Wdzieczak-Bakala; J Melville; A Riches
Journal:  Cell Prolif       Date:  1992-11       Impact factor: 6.831

View more
  32 in total

1.  A role for the renin-angiotensin system in hematopoiesis.

Authors:  Tea Soon Park; Elias T Zambidis
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

Review 2.  Angiotensin-converting enzyme overexpression in myelocytes enhances the immune response.

Authors:  Kenneth E Bernstein; Romer A Gonzalez-Villalobos; Jorge F Giani; Kandarp Shah; Ellen Bernstein; Tea Janjulia; Yosef Koronyo; Peng D Shi; Maya Koronyo-Hamaoui; Sebastien Fuchs; Xiao Z Shen
Journal:  Biol Chem       Date:  2014-10       Impact factor: 3.915

Review 3.  ACE overexpression in myelomonocytic cells: effect on a mouse model of Alzheimer's disease.

Authors:  Maya Koronyo-Hamaoui; Kandarp Shah; Yosef Koronyo; Ellen Bernstein; Jorge F Giani; Tea Janjulia; Keith L Black; Peng D Shi; Romer A Gonzalez-Villalobos; Sebastien Fuchs; Xiao Z Shen; Kenneth E Bernstein
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

4.  Effect of angiotensin II on cord blood CD34+ cells expansion in vitro.

Authors:  Cheng Peng; Ping Zou; Yanping Ma; Zongbo Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 5.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

Review 6.  Newer approaches to genetic modeling in mice: tissue-specific protein expression as studied using angiotensin-converting enzyme (ACE).

Authors:  Hong D Xiao; Sebastien Fuchs; Kristen Frenzel; Justin M Cole; Kenneth E Bernstein
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

7.  Do alterations of endogenous angiotensin II levels regulate erythropoietin production in humans?

Authors:  S Freudenthaler; P Benöhr; A Grenz; T Selzer; T Schmidt; K Mörike; H Osswald; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  2003-10       Impact factor: 4.335

8.  Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance.

Authors:  Anura P Jayasooriya; Michael L Mathai; Lesley L Walker; Denovan P Begg; Derek A Denton; David Cameron-Smith; Gary F Egan; Michael J McKinley; Paula D Rodger; Andrew J Sinclair; John D Wark; Harrison S Weisinger; Mark Jois; Richard S Weisinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-28       Impact factor: 11.205

9.  Preservation of intracellular renin expression is insufficient to compensate for genetic loss of secreted renin.

Authors:  Di Xu; Giulianna R Borges; Justin L Grobe; Christopher J Pelham; Baoli Yang; Curt D Sigmund
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

10.  Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathways.

Authors:  Crystal A West; Stefan Shaw; Jennifer M Sasser; Andrea Fekete; Tyler Alexander; Mark W Cunningham; Shyama M E Masilamani; Chris Baylis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-09-25       Impact factor: 3.619

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.